½ÃÀ庸°í¼­
»óǰÄÚµå
1404576

¹Ì±¹ÀÇ º´¿ø ½Ã¼³ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ȯÀÚ ¼­ºñ½ºº°, ½Ã¼³ À¯Çüº°, º´»ó ±Ô¸ðº°, ¼­ºñ½º À¯Çüº°, ºÎ¹®º° ¿¹Ãø(2023-2030³â)

U.S. Hospital Facilities Market Size, Share & Trends Analysis Report By Patient Service, By Facility Type (Private Hospitals, Public/Community Hospitals), By Bed Size, By Service Type, And Segment Forecasts, 2023 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 98 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹Ì±¹ º´¿ø ½Ã¼³ ½ÃÀå ¼ºÀå ¹× µ¿Çâ:

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¹Ì±¹ º´¿ø ½Ã¼³ ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 2Á¶ 5,404¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023³âºÎÅÍ 2030³â±îÁö 7.7%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. ¿ø°Ý ÀÇ·á, ¸ð¹ÙÀÏ ¾Û, ÀΰøÁö´É, ¿þ¾î·¯ºí ±â±â µîÀÇ ±â¼ú ¹ßÀüÀÌ ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹Ì±¹ ÀÇ·á ½Ã½ºÅÛÀÇ ¼ö¿ä¿Í °ø±ÞÀÇ °ÝÂ÷°¡ ºü¸£°Ô È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ´Â ÁַΠȯÀÚ ¼öÀÇ Áõ°¡¿Í ÇÊ¿äÇÑ Ä¡·á¸¦ Á¦°øÇÒ ¼ö ÀÖ´Â ÀÚ¿øÀÌ Á¦ÇѵǾî Àֱ⠶§¹®ÀÔ´Ï´Ù.

¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ º¯È­¿Í Á½ĻýȰÀÇ Áõ°¡·Î ÀÎÇØ ¹Ì±¹ Àα¸ÀÇ Áúº´ ÇÁ·ÎÇÊÀÌ º¯È­Çϰí ÀÖ½À´Ï´Ù. ¾Ï, ´ç´¢º´, ½ÉÇ÷°ü Áúȯ°ú °°Àº ºñ°¨¿°¼º ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, CDCÀÇ º¸°í¿¡ µû¸£¸é, ´ç´¢º´ À¯º´·üÀº 2022³â 3,730¸¸ ¸íÀ¸·Î ÃßÁ¤µË´Ï´Ù. ½Ä½À°ü, ¿îµ¿ ºÎÁ·, Èí¿¬ µîÀ¸·Î ÀÎÇÑ »ýȰ½À°üº´Àº ¼ºº°, ¿¬·É, À¯Àü°ú °ü°è¾øÀÌ Ã¼³» »ê¼Ò ³óµµ ÀúÇÏ, È£Èí°ï¶õ µî ¿©·¯ °¡Áö °Ç°­ ¹®Á¦¸¦ ÀÏÀ¸Åµ´Ï´Ù. ¸¸¼ºÁúȯÀÇ À¯º´·üÀº ±¹³»¿¡¼­µµ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

COVID-19ÀÇ ´ëÀ¯ÇàÀº ¹Ì±¹ ÀÇ·á ½Ã½ºÅÛ¿¡ ¾Ç¿µÇâÀ» ³¢ÃƽÀ´Ï´Ù. ¹Ì±¹ Àü¿ªÀÇ ÀÇ·á ½Ã¼³Àº ÀçÁ¤ÀûÀ¸·Î³ª Á¶Á÷ÀûÀ¸·Î ¾î·Á¿òÀ» °Þ¾ú½À´Ï´Ù. Àü¿°º´ÀÌ ½ÃÀÛµÉ ¶§ º´¿øÀÌ ÃëÇÑ ÁÖ¿ä Á¶Ä¡ Áß Çϳª´Â ¼±ÅÃÀû Ä¡·á¸¦ Áö¿¬½ÃŰ´Â °ÍÀ̾ú´Âµ¥, ÀÌ´Â º´¿ø¿¡ ¸·´ëÇÑ ÀçÁ¤Àû ¼Õ½ÇÀ» °¡Á®¿Ô½À´Ï´Ù. AHA COVID-19 ÀçÁ¤ ¿µÇâ º¸°í¼­ ÃßÁ¤¿¡ µû¸£¸é, Àü¿°º´ ±â°£ µ¿¾È ¼­ºñ½º Áß´ÜÀ¸·Î ÀÎÇØ ¿¬¹æÁ¤ºÎ°¡ ¾Æ´Ñ º´¿øÀº 2020³â 3¿ùºÎÅÍ 2020³â 6¿ù±îÁö 2020³â 6¿ù±îÁö 4°³¿ù µ¿¾È ¾à 1,614¾ï ´Þ·¯ÀÇ ¼öÀÔÀ» ÀÒ¾ú½À´Ï´Ù. ¶ÇÇÑ, ȯÀÚ ¼öÀÇ °¨¼Ò´Â ´ëºÎºÐ ¼±ÅÃÀû Ä¡·áÀÇ Ãë¼Ò·Î ÀÎÇØ ¼ö¹é¸¸ ´Þ·¯ÀÇ ¼öÀÔÀ» ÀÒ¾úÀ¸¸ç, CovidSurg¿¡ µû¸£¸é Àü¿°º´À¸·Î ÀÎÇÑ È¥¶õÀÇ Ã¹ 3°³¿ù µ¿¾È 2,840¸¸ °ÇÀÇ ¼ö¼úÀÌ Ãë¼ÒµÇ°Å³ª ¿¬±âµÇ¾ú´Ù°í ÇÕ´Ï´Ù. ¾Õ¼­ ¾ð±ÞÇÑ ¿äÀεéÀº ½ÃÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù.

¹Ì±¹ º´¿ø ½Ã¼³ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®:

  • ¼øÈ¯±â ºÐ¾ß°¡ ½ÃÀåÀ» µ¶Á¡Çϰí 2022³â¿¡´Â ¾à 20%ÀÇ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È ½ÃÀåÀ» ´õ¿í µ¶Á¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • °ø°ø/Áö¿ªº´¿ø ºÎ¹®Àº 2022³â 52% ÀÌ»óÀÇ Á¡À¯À²À» Â÷ÁöÇÏ¸ç ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. Áö¿ª º´¿øÀº º´»ó ¼ö°¡ °¡Àå ¸¹°í, ´Ù¾çÇÑ ¼­ºñ½º¸¦ ÅëÇØ ´Ù¾çÇÑ Ä¡·á ¿µ¿ªÀ» Á¦°øÇÕ´Ï´Ù.
  • ¿Ü·¡È¯ÀÚ ¼­ºñ½º ºÎ¹®Àº 2022³â ¾à 51%ÀÇ Á¡À¯À²·Î ½ÃÀåÀ» Àå¾ÇÇßÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È 9.0%ÀÇ CAGR·Î °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â ºÎ¹®ÀÌ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
  • º´»ó ±Ô¸ð¿¡ µû¶ó ½ÃÀåÀº 0-99º´»ó, 100-199º´»ó, 200-299º´»ó, 300º´»ó ÀÌ»óÀ¸·Î ±¸ºÐµÇ¸ç, 2022³â ½ÃÀå Á¡À¯À²Àº 0-99º´»óÀÌ 53.2%·Î ¾ÐµµÀûÀ̾ú½À´Ï´Ù. ÀÌ ºÎ¹®Àº ÁÖ·Î Àα¸ ¹Ðµµ°¡ ³·Àº Áö¹æ°ú ¿Üµý Áö¿ª¿¡ ¼­ºñ½º¸¦ Á¦°øÇÏ´Â ¼Ò±Ô¸ð º´¿øÀ¸·Î ±¸¼ºµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹Ì±¹ÀÇ º´¿ø ½Ã¼³ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • »óºÎ ½ÃÀå Àü¸Á
    • °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
  • º¸±Þ°ú ¼ºÀå Àü¸Á ¸ÅÇÎ
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ¹Ì±¹ÀÇ º´¿ø ½Ã¼³ ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå ¹Ì±¹ÀÇ º´¿ø ½Ã¼³ ½ÃÀå : ȯÀÚ ¼­ºñ½º¿Í µ¿Ç⠺м®

  • ¹Ì±¹ÀÇ º´¿ø ½Ã¼³ ½ÃÀå : Áß¿äÇÑ Æ÷ÀÎÆ®
  • ¹Ì±¹ÀÇ º´¿ø ½Ã¼³ ½ÃÀå : ȯÀÚ ¼­ºñ½º µ¿Çâ°ú ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â ¹× 2030³â
  • ÀÔ¿ø ¼­ºñ½º
  • ¿Ü·¡ Áø·á

Á¦5Àå ¹Ì±¹ÀÇ º´¿ø ½Ã¼³ ½ÃÀå : ½Ã¼³ À¯Çü°ú µ¿Ç⠺м®

  • ¹Ì±¹ÀÇ º´¿ø ½Ã¼³ ½ÃÀå : Áß¿äÇÑ Æ÷ÀÎÆ®
  • ¹Ì±¹ÀÇ º´¿ø ½Ã¼³ ½ÃÀå : ½Ã¼³ À¯Çü µ¿Çâ°ú ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â ¹× 2030³â
  • °ø¸³/Áö¿ª º´¿ø
  • ±¹¿µ¡¤¿¬¹æ º´¿ø
  • »ç¸³ º´¿ø

Á¦6Àå ¹Ì±¹ÀÇ º´¿ø ½Ã¼³ ½ÃÀå : ¼­ºñ½º À¯Çü°ú µ¿Ç⠺м®

  • ¹Ì±¹ÀÇ º´¿ø ½Ã¼³ ½ÃÀå : Áß¿äÇÑ Æ÷ÀÎÆ®
  • ¹Ì±¹ÀÇ º´¿ø ½Ã¼³ ½ÃÀå : ¼­ºñ½º À¯Çü µ¿Çâ°ú ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â ¹× 2030³â
  • ±Þ¼º±â Ä¡·á
  • ½ÉÇ÷°ü
  • ¾Ï Ä¡·á
  • ½Å°æÀçȰ¡¤Á¤½Å°ú ¼­ºñ½º
  • º´¸®ÇÐ ¿¬±¸½Ç, Áø´Ü, ¿µ»ó ó¸®
  • »êºÎÀΰú
  • ±âŸ

Á¦7Àå ¹Ì±¹ÀÇ º´¿ø ½Ã¼³ ½ÃÀå : º´»ó ±Ô¸ð ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹®ÀÇ Á¤ÀÇ
  • ¹Ì±¹ÀÇ º´¿ø ½Ã¼³ ½ÃÀå : ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ º´¿ø ½Ã¼³ ½ÃÀå : º´»ó ±Ô¸ð ÃßÁ¤°ú ½ÃÀå Á¡À¯À² ºÐ¼®
  • 0-99
  • 100-199
  • 200-299
  • 300 ÀÌ»ó

Á¦8Àå °æÀï »óȲ

  • ÁÖ¿ä ½ÃÀå ÁøÃâ ±â¾÷¿¡ ÀÇÇÑ ÃÖ±ÙÀÇ µ¿Çâ°ú ¿µÇ⠺м®
  • ½ÃÀå ÁøÃâ ±â¾÷ ºÐ·ù
    • The Johns Hopkins Hospital
    • Mayo Clinic
    • Cleveland Clinic
    • Cedars-Sinai
    • Massachusetts General Hospital
    • UCSF HEALTH
    • NewYork-Presbyterian Hospital
    • Brigham and Women's Hospital
    • Ronald Regan UCLA Medical Center
    • Northwestern Memorial Hospital
ksm 24.01.16

U.S. Hospital Facilities Market Growth & Trends:

The U.S. hospital facilities market size is anticipated to reach USD 2540.4 billion by 2030 and is anticipated to grow at a CAGR of 7.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. Technological advancements, such as telehealth, mobile apps, artificial intelligence, and wearable devices, are boosting market growth. Furthermore, the demand and supply gap in the U.S. healthcare system is increasing rapidly. This can mainly be attributed to the growing number of patients and the limited resources available to provide necessary care.

Lifestyle changes and an increase in the number of sedentary jobs are transforming the disease profile of the U.S. population. Noncommunicable diseases such as cancer, diabetes, and cardiovascular diseases are increasing in prevalence. For instance, according to a CDC report, diabetes prevalence had risen to an estimated 37.3 million patients in 2022. Lifestyle diseases due to poor dietary habits, lack of exercise, and smoking, irrespective of gender, age, & heredity, lead to several health problems, such as low body oxygen levels & breathing difficulties. Chronic disease prevalence is expected to rise in the country.

The COVID-19 pandemic adversely impacted the U.S. healthcare system. Healthcare facilities across the U.S. were facing both financial and organizational difficulties. One of the major steps taken by the hospitals at the start of the pandemic was to delay elective procedures, which culminated in monumental monetary losses for the hospitals. According to AHA COVID-19 Financial Impact Report Estimates, due to canceled services during the pandemic, non-federal hospitals lost around USD 161.4 billion in income during the four months from March 2020 to June 2020. Furthermore, the decline in visits was mostly attributed to the cancellation of elective treatments, which resulted in a revenue loss of millions of dollars. According to CovidSurg, 28.4 million surgeries were canceled or postponed during the first 3 months of disruption caused by the pandemic. The aforementioned factors negatively impacted the market.

U.S. Hospital Facilities Market Report Highlights:

  • The cardiovascular segment dominated the market, accounting for a share of around 20% in 2022. The segment is further expected to dominate the market over the forecast period.
  • The public/community hospitals segment dominated the market with a share of over 52% in 2022. Community hospitals hold the highest number of patient beds and offer a wide variety of care areas through different services.
  • The outpatient services segment dominated the market with a share of around 51% in 2022 and is additionally poised to be the fastest-growing segment with a CAGR of 9.0% over the forecast period.
  • Based on bed size, the market is segmented into 0-99, 100-199, 200-299, and 300-more. The 0-99 segment dominated the market in 2022 with a revenue share of 53.2%. This segment comprises small hospitals that primarily serve rural or remote areas with low population density.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Patient service
    • 1.1.2. Facility type
    • 1.1.3. Service type
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Patient service
    • 2.2.2. Facility type
    • 2.2.3. Service type
  • 2.3. Competitive Insights

Chapter 3. U.S. Hospital Facilities Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. U.S. Hospital Facilities Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. U.S. Hospital Facilities Market: Patient Service & Trend Analysis

  • 4.1. U.S. Hospital Facilities Market: Key Takeaways
  • 4.2. U.S. Hospital Facilities Market: Patient Service Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Inpatient Services
    • 4.3.1. Inpatient services market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.4. Outpatient Services
    • 4.4.1. Outpatient services market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. U.S. Hospital Facilities Market: Facility Type & Trend Analysis

  • 5.1. U.S. Hospital Facilities Market: Key Takeaways
  • 5.2. U.S. Hospital Facilities Market: Facility Type Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Public/Community Hospitals
    • 5.3.1. Public/Community Hospitals market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.4. State Owned & Federal Hospitals
    • 5.4.1. State owned & federal hospitals market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.5. Private Hospitals
    • 5.5.1. Private hospitals market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 6. U.S. Hospital Facilities Market: Service Type & Trend Analysis

  • 6.1. U.S. Hospital Facilities Market: Key Takeaways
  • 6.2. U.S. Hospital Facilities Market: Service Type Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Acute Care
    • 6.3.1. Acute care market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 6.4. Cardiovascular
    • 6.4.1. Cardiovascular market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 6.5. Cancer Care
    • 6.5.1. Cancer care market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 6.6. Neurorehabilitation & Psychiatry Services
    • 6.6.1. Neurorehabilitation & psychiatry services market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 6.7. Pathology Lab, Diagnostics, And Imaging
    • 6.7.1. Pathology lab, diagnostics, and imaging market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 6.8. Obstetrics & Gynecology
    • 6.8.1. Obstetrics & Gynecology market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 6.9. Others
    • 6.9.1. Other market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 7. U.S. Hospital Facilities Market: Bed Size Estimates & Trend Analysis

  • 7.1. Segment Definitions
  • 7.2. U.S. Hospital Facilities Market: Segment Dashboard
  • 7.3. U.S. Hospital Facilities Market: Bed Size Movement & Market Share Analysis
  • 7.4. 0-99
    • 7.4.1. 0-99 Market, 2018 - 2030 (USD Billion)
  • 7.5. 100-199
    • 7.5.1. 100-199 Market, 2018 - 2030 (USD Billion)
  • 7.6. 200-299
    • 7.6.1. 200-299 Market, 2018 - 2030 (USD Billion)
  • 7.7. 300-more
    • 7.7.1. 300-more Market, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. The Johns Hopkins Hospital
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Mayo Clinic
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Cleveland Clinic
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Cedars-Sinai
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Massachusetts General Hospital
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. UCSF HEALTH
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. NewYork-Presbyterian Hospital
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Brigham and Women's Hospital
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Ronald Regan UCLA Medical Center
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Northwestern Memorial Hospital
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦